Radiation dose measurement developer VeriTeQ has inked an agreement with North Carolina State University (NCSU) to license patents for its Q Inside SmartMarker and OneDose radiation dosimetry products.
Under terms of the agreement, VeriTeQ will license 24 patents that apply to Q Inside SmartMarker, an implantable radiation sensor for use in breast and prostate cancer patients undergoing photon external-beam treatments, as well as its OneDose external radiation sensing system, which consists of disposable sensors that attach to the patient's skin using a basic adhesive and a scanner that reads the sensor.
Previously, the patents were made available to VeriTeQ through a sublicense agreement. The new, direct agreement with NCSU is effective immediately, according to the firm.
